COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
21 02 2022
Historique:
pubmed: 22 2 2022
medline: 12 3 2022
entrez: 21 2 2022
Statut: epublish

Résumé

SARS-CoV-2 serological tests are used to assess the infection seroprevalence within a population. This study aims at assessing potential biases in estimating infection prevalence amongst healthcare workers (HCWs) when different diagnostic criteria are considered. A multi-site cross-sectional study was carried out in April-September 2020 amongst 1.367 Italian HCWs. SARS-CoV-2 prevalence was assessed using three diagnostic criteria: RT-PCR on nasopharyngeal swab, point-of-care fingerprick serological test (POCT) result and COVID-19 clinical pathognomonic presentation. A logistic regression model was used to estimate the probability of POCT-positive result in relation to the time since infection (RT-PCR positivity). Among 1.367 HCWs, 69.2% were working in COVID-19 units. Statistically significant differences in age, role and gender were observed between COVID-19/non-COVID-19 units. Prevalence of SARS-CoV-2 infection varied according to the criterion considered: 6.7% for POCT, 8.1% for RT-PCR, 10.0% for either POCT or RT-PCR, 9.6% for infection pathognomonic clinical presentation and 17.6% when at least one of the previous criteria was present. The probability of POCT-positive result decreased by 1.1% every 10 days from the infection. This study highlights potential biases in estimating SARS-CoV-2 point-prevalence data according to the criteria used. Although informative on infection susceptibility and herd immunity level, POCT serological tests are not the best predictors of previous COVID-19 infections for public health monitoring programmes.

Identifiants

pubmed: 35184764
doi: 10.1017/S0950268822000280
pii: S0950268822000280
pmc: PMC8914136
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e48

Subventions

Organisme : This study was funded by Cariverona Foundation (ENACT Fund 2020), Italy

Références

Am J Clin Pathol. 2020 Jun 8;154(1):1-3
pubmed: 32412044
J Clin Virol. 2016 Mar;76:8-13
pubmed: 26774543
PLoS One. 2020 Dec 28;15(12):e0244477
pubmed: 33370384
Lancet. 2020 Jul 25;396(10246):e6-e7
pubmed: 32653078
Infect Control Hosp Epidemiol. 2021 Feb;42(2):212-214
pubmed: 32746953
J Med Virol. 2020 Jun;92(6):577-583
pubmed: 32162702
J Hosp Infect. 2021 Feb;108:120-134
pubmed: 33212126
Clin Microbiol Infect. 2021 Feb;27(2):182-191
pubmed: 32120036
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
Clin Chem Lab Med. 2020 Aug 26;58(12):2107-2111
pubmed: 32845861
Lancet Respir Med. 2020 Sep;8(9):885-894
pubmed: 32717210
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
Sex Transm Infect. 2017 Dec;93(S4):S51-S58
pubmed: 29223963
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):269-283
pubmed: 33589829
Science. 2021 Jan 8;371(6525):126-127
pubmed: 33414210
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33080168
Am J Emerg Med. 2020 Sep;38(9):1727-1731
pubmed: 32738467
Am J Clin Pathol. 2020 Aug 5;154(3):425-426
pubmed: 32577723
Malays J Pathol. 2020 Apr;42(1):13-21
pubmed: 32342927
J Infect. 2020 Jun;80(6):656-665
pubmed: 32283155
Am J Otolaryngol. 2020 Sep - Oct;41(5):102581
pubmed: 32563019
Int J Epidemiol. 2021 May 17;50(2):400-409
pubmed: 33434269
Cochrane Database Syst Rev. 2020 Aug 26;8:CD013705
pubmed: 32845525
Am J Infect Control. 2021 Jan;49(1):21-29
pubmed: 32659413
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
BMJ. 2020 Oct 28;371:m3944
pubmed: 33115772

Auteurs

Maddalena Cordioli (M)

Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Massimo Mirandola (M)

Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
School of Health Sciences, University of Brighton, Brighton, UK.

Lorenzo Gios (L)

Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Fondazione Bruno Kessler, Trento, Italy.

Sebastiano Gaspari (S)

Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Maria Carelli (M)

Microbiology and Virology Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Virginia Lotti (V)

Microbiology and Virology Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Angela Sandri (A)

Microbiology and Virology Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Caterina Vicentini (C)

Microbiology Unit, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Davide Gibellini (D)

Microbiology and Virology Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Elena Carrara (E)

Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Evelina Tacconelli (E)

Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH